We are live on ! Find out more
LAB icon

Standard BioTools
LAB

144 hedge funds and large institutions have $480M invested in Standard BioTools in 2024 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 39 increasing their positions, 35 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,045% more call options, than puts

Call options by funds: $1.26M | Put options by funds: $110K

11% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 35

3% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 34

1% less funds holding

Funds holding: 145 → 144 (-1)

18.23% less ownership

Funds ownership: 91.46% → 73.23% (-18%)

33% less capital invested

Capital invested by funds: $719M → $480M (-$239M)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
144
Holders Change
-1
Holders Change %
-0.69%
% of All Funds
2.08%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
35
Increased
39
Reduced
35
Closed
34
Calls
$1.26M
Puts
$110K
Net Calls
+$1.15M
Net Calls Change
-$1.96M

Top Buyers

1
BlackRock
BlackRock
New York
+$39.8M
2
Morgan Stanley
Morgan Stanley
New York
+$13M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$9.99M
4
State Street
State Street
Massachusetts
+$7.32M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$7.26M

Top Sellers

1
ICM
Indaba Capital Management
California
-$20M
2
Millennium Management
Millennium Management
New York
-$19.9M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$9.4M
4
Goldman Sachs
Goldman Sachs
New York
-$6.44M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$4.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
1
Casdin Capital
New York
$113M +$5.02M +2,052,072 +3%
Viking Global Investors
2
Viking Global Investors
Connecticut
$104M – – –
BlackRock
3
BlackRock
New York
$38.5M +$39.8M +16,302,778 +299%
Vanguard Group
4
Vanguard Group
Pennsylvania
$28.3M +$7.26M +2,969,115 +23%
Morgan Stanley
5
Morgan Stanley
New York
$22.9M +$13M +5,316,665 +70%
AIM
6
ARK Investment Management
Florida
$22.4M -$887K -363,049 -3%
Sumitomo Mitsui Trust Group
7
Sumitomo Mitsui Trust Group
Japan
$18.8M +$4.37M +1,788,780 +20%
NAMA
8
Nikko Asset Management Americas
New York
$18.7M +$4.37M +1,788,780 +20%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$12M +$9.99M +4,087,943 +151%
TM
10
Tikvah Management
North Carolina
$11.6M – – –
Millennium Management
11
Millennium Management
New York
$11M -$19.9M -8,151,206 -57%
State Street
12
State Street
Massachusetts
$7.68M +$7.32M +2,995,795 +223%
Neuberger Berman Group
13
Neuberger Berman Group
New York
$7.32M -$1.49M -607,677 -13%
Primecap Management
14
Primecap Management
California
$5.33M -$32.3K -13,200 -0.4%
Barclays
15
Barclays
United Kingdom
$5.05M -$2.7M -1,102,655 -28%
NFGH
16
Nan Fung Group Holdings
Hong Kong
$3.33M – – –
SPC
17
Slate Path Capital
New York
$2.86M – – –
Qube Research & Technologies (QRT)
18
Qube Research & Technologies (QRT)
United Kingdom
$2.18M -$1.19M -487,835 -28%
Renaissance Technologies
19
Renaissance Technologies
New York
$1.78M -$609K -249,300 -20%
Northern Trust
20
Northern Trust
Illinois
$1.77M +$532K +217,449 +28%
Balyasny Asset Management
21
Balyasny Asset Management
Illinois
$1.77M -$9.4M -3,846,889 -79%
NIM
22
Needham Investment Management
New York
$1.74M -$342K -140,000 -12%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$1.74M +$2.18M +893,383 +1,020%
JCP
24
Jennifer C. Price
$1.73M – – –
ICM
25
Invenomic Capital Management
Massachusetts
$1.68M +$2.32M +950,114 New
1
2 3 4 5

LAB Hedge Fund Activity: Q2 2024 in Review

144 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q2 2024, worth a combined $480M — down 33% from $719M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new LAB positions and 34 closed out — a net gain of 1 holder — while 39 added to existing stakes and 35 trimmed.

The largest buyer was BlackRock, adding an estimated $39.8M. The largest seller was Indaba Capital Management, exiting entirely with an estimated $20M sold.

  • 144 institutional investors held Standard BioTools (LAB) as of Q2 2024, down from 145 in Q1 2024.
  • Funds reported $480M of Standard BioTools stock for Q2 2024, down 33% quarter-over-quarter.
  • 35 funds opened new Standard BioTools positions in Q2 2024 and 34 closed out, a net change of +1 holder.
  • The largest Standard BioTools buyer in Q2 2024 was BlackRock, an estimated $39.8M added.
  • The largest Standard BioTools seller in Q2 2024 was Indaba Capital Management, an estimated $20M sold.

Based on aggregated 13F filings for Q2 2024.